Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 42,279 | 0 | 458 | 40,000 | 0 |
| Cost of Goods | 2,582 | N/A | 346 | N/A | N/A |
| Gross Profit | 39,697 | N/A | 112 | 40,000 | N/A |
| Operating Expenses | 194,906 | 67,569 | 76,208 | 113,313 | 74,277 |
| Operating Income | -154,627 | -67,569 | -75,750 | -73,313 | -74,277 |
| Interest Expense | 23,542 | 2,057 | 521 | 340 | 35 |
| Other Income | 15,040 | 15,731 | 7,823 | 18,066 | 9,312 |
| Pre-tax Income | -163,129 | -53,895 | -68,448 | -55,587 | -65,000 |
| Income Tax | 10,289 | 474 | 253 | -18 | -146 |
| Net Income Continuous | -173,418 | -54,369 | -68,701 | -55,569 | -64,854 |
| Net Income | $-173,418 | $-54,369 | $-68,701 | $-55,569 | $-65,146 |
| EPS Basic Total Ops | -2.13 | -0.69 | -1.04 | -0.94 | -2.00 |
| EPS Basic Continuous Ops | -2.13 | -0.69 | -1.04 | -0.94 | -1.97 |
| EPS Diluted Total Ops | -2.13 | -0.69 | -1.04 | -0.94 | -2.00 |
| EPS Diluted Continuous Ops | -2.13 | -0.69 | -1.04 | -0.94 | -1.97 |
| EPS Diluted Before Non-Recurring Items | -2.16 | -0.72 | -1.04 | -0.96 | -2.57 |
| EBITDA(a) | $-152,265 | $-66,776 | $-75,034 | $-72,570 | $-73,644 |